百洋医药(301015)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

301015 百洋医药

已收盘 12-23 15:00:00

{"stockData":{"symbol":"301015","market":"SZ","secType":"STK","nameCN":"百洋医药","latestPrice":25.92,"timestamp":1734937398000,"preClose":26.69,"halted":0,"volume":2053364,"delay":0,"floatShares":526000000,"shares":526000000,"eps":1.5281,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.77,"latestTime":"12-23 15:00:00","open":26.8,"high":26.82,"low":25.88,"amount":53774200,"amplitude":0.0352,"askPrice":25.92,"askSize":44,"bidPrice":25.91,"bidSize":4,"shortable":0,"etf":0,"ttmEps":1.5281,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735003800000},"adr":0,"adjPreClose":26.69,"symbolType":"stock","openAndCloseTimeList":[[1734917400000,1734924600000],[1734930000000,1734937200000]],"highLimit":29.36,"lowLimit":24.02,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":525613491,"pbRate":6.35,"roa":"--","roe":"22.95%","epsLYR":1.25,"committee":0.228986,"marketValue":13624000000,"floatMarketCap":13624000000,"peRate":16.962241,"changeRate":-0.0288,"turnoverRate":0.0039,"status":1},"requestUrl":"/m/hq/s/301015/wiki","defaultTab":"wiki","newsList":[{"id":"2493472229","title":"百洋医药新提交“善维他”商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2493472229","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493472229?lang=zh_cn&edition=full","pubTime":"2024-12-21 05:52","pubTimestamp":1734731557,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日青岛百洋医药股份有限公司新提交“善维他”商标注册申请。商标申请详情如下：今年以来青岛百洋医药股份有限公司新申请注册商标88件，截止目前公司共持有注册商标437件，另有101件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122100008572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"gpt_icon":0},{"id":"2493478949","title":"百洋医药获得外观设计专利授权：“包装盒（迪巧小粉条液体钙）”","url":"https://stock-news.laohu8.com/highlight/detail?id=2493478949","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493478949?lang=zh_cn&edition=full","pubTime":"2024-12-21 03:07","pubTimestamp":1734721638,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示百洋医药（301015）新获得一项外观设计专利授权，专利名为“包装盒（迪巧小粉条液体钙）”，专利申请号为CN202430273801.X，授权日为2024年12月20日。专利摘要：1.本外观设计产品的名称：包装盒（迪巧小粉条液体钙）。2.本外观设计产品的用途：用于盛装物品。3.本外观设计产品的设计要点：在于图中所示图案。4.最能表明设计要点的图片或照片：设计1主视图。5.指定设计1为基本设计。今年以来百洋医药新获得专利授权5个，较去年同期增加了400%。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122100005544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2492903849","title":"身兼4职、年薪250多万，青岛上市公司百洋医药元老级高管辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2492903849","media":"市场资讯","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492903849?lang=zh_cn&edition=full","pubTime":"2024-12-18 17:33","pubTimestamp":1734514380,"startTime":"0","endTime":"0","summary":"王国强曾在A+H股上市公司丽珠集团历任多个职务，而百洋医药董事长及多名董事、高管也有在丽珠集团的任职经历。百洋医药公告，辞职后王国强将不再担任公司任何职务。2023年他从百洋医药获得的税前报酬总额为253.56万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-12-18/doc-inczwpwv7796924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2492095735","title":"百洋医药董事王国强辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2492095735","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492095735?lang=zh_cn&edition=full","pubTime":"2024-12-17 20:35","pubTimestamp":1734438900,"startTime":"0","endTime":"0","summary":"北京商报讯（记者 丁宁）12月17日晚间，百洋医药（301015）发布公告称，公司董事会近日收到了王国强的书面辞职报告。王国强因其个人原因申请辞去公司董事、副总经理、财务总监、董事会秘书的职务，辞职后不再担任公司任何职务。百洋医药表示，为确保公司董事会工作的顺利开展，在公司正式聘任新的董事会秘书之前，将由公司董事长付钢代行董事会秘书职责。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-12-17/doc-inczurfm1472880.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-12-17/doc-inczurfm1472880.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2492934106","title":"百洋医药(301015.SZ)财务总监王国强辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2492934106","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492934106?lang=zh_cn&edition=full","pubTime":"2024-12-17 18:25","pubTimestamp":1734431121,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百洋医药(301015.SZ)公告，公司董事会近日收到了王国强先生的书面辞职报告。王国强先生因其个人原因申请辞去公司董事、副总经理、财务总监、董事会秘书的职务，辞职后不再担任公司任何职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226058.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2490239890","title":"百洋医药新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2490239890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490239890?lang=zh_cn&edition=full","pubTime":"2024-12-12 04:47","pubTimestamp":1733950045,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日青岛百洋医药股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来青岛百洋医药股份有限公司新申请注册商标58件，截止目前公司共持有注册商标437件，另有71件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200003695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2490281890","title":"百洋医药新提交11件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2490281890","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490281890?lang=zh_cn&edition=full","pubTime":"2024-12-12 04:47","pubTimestamp":1733950031,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日青岛百洋医药股份有限公司新提交11件商标注册申请。商标申请详情如下：今年以来青岛百洋医药股份有限公司新申请注册商标58件，截止目前公司共持有注册商标437件，另有71件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200003681.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"gpt_icon":0},{"id":"2490061505","title":"百洋医药(301015.SZ)拟向参股公司中山安士合计增资2429.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490061505","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490061505?lang=zh_cn&edition=full","pubTime":"2024-12-10 16:53","pubTimestamp":1733820814,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百洋医药(301015.SZ)公告，根据业务发展需要，公司的参股公司安士制药(中山)有限公司(简称“中山安士”)拟将注册资本由人民币2665.74万元增加至人民币1亿元，新增注册资本人民币7334.26万元，由全体股东按持股比例进行同比例增资。公司及全资子公司百洋集团有限公司(简称“百洋有限”)拟按持股比例向中山安士增资2429.04万元。本次增资完成后，公司及百洋有限合计认缴中山安士注册资本3311.91万元，合计持股比例为33.1191%。本次增资不会导致公司合并报表范围发生变更。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2486391866","title":"百洋医药：11月28日接受机构调研，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2486391866","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486391866?lang=zh_cn&edition=full","pubTime":"2024-11-28 18:33","pubTimestamp":1732790000,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年11月28日百洋医药发布公告称公司于2024年11月28日接受机构调研。百洋医药2024年三季报显示，公司主营收入61.44亿元，同比上升2.65%；归母净利润6.41亿元，同比上升17.42%；扣非净利润6.1亿元，同比上升26.22%；其中2024年第三季度，公司单季度主营收入25.49亿元，同比上升8.46%；单季度归母净利润2.72亿元，同比上升11.86%；单季度扣非净利润2.4亿元，同比上升24.76%；负债率63.53%，投资收益3798.08万元，财务费用5706.15万元，毛利率35.72%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112800030034.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"gpt_icon":0},{"id":"2485268104","title":"百洋医药（301015）股东百洋医药集团有限公司质押1000万股，占总股本1.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485268104","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485268104?lang=zh_cn&edition=full","pubTime":"2024-11-22 21:21","pubTimestamp":1732281672,"startTime":"0","endTime":"0","summary":"证券之星消息，百洋医药11月22日公开信息显示，股东百洋医药集团有限公司向云南国际信托有限公司合计质押1000.0万股，占总股本1.9%。百洋医药主营业务：为医药产品生产企业提供商业化整体解决方案,涵盖品牌运营、批发配送及零售三个板块。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200042659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"gpt_icon":0},{"id":"2485235265","title":"11月22日百洋医药跌5.34%，安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485235265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485235265?lang=zh_cn&edition=full","pubTime":"2024-11-22 16:34","pubTimestamp":1732264484,"startTime":"0","endTime":"0","summary":"证券之星消息，11月22日百洋医药跌5.34%，收盘报26.43元，换手率0.53%，成交量2.81万手，成交额7623.79万元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共23家，其中持有数量最多的公募基金为安信医药健康股票A。安信医药健康股票A目前规模为14.92亿元，最新净值0.9898，较上一交易日下跌0.33%，近一年下跌19.92%。安信医药健康股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200026252.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2483003806","title":"百洋医药：子公司与北京华昊中天签订市场推广服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2483003806","media":"中国财富通","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483003806?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:06","pubTimestamp":1731593178,"startTime":"0","endTime":"0","summary":"中国财富通11月14日 - 百洋医药（301015）公告称，近日，公司全资子公司百洋智合与北京华昊中天签订《市场推广服务协议》，约定北京华昊中天指定百洋智合在区域内进行指定产品（优替德隆注射液，商品名：优替帝）的独家市场推广服务。同日，百洋智合与北京华昊中天、成都华昊中天签订《市场推广服务协议补充协议》，各方同意授权百洋智合按照协议约定在区域内独占和排他地推广指定产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=B8FHv8ByeRs%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0250","301015"],"gpt_icon":0},{"id":"2483840518","title":"百洋医药最新公告：全资子公司签订市场推广服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2483840518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483840518?lang=zh_cn&edition=full","pubTime":"2024-11-14 16:48","pubTimestamp":1731574122,"startTime":"0","endTime":"0","summary":"百洋医药公告，近日，公司全资子公司北京百洋智合医学成果转化服务有限公司（简称“百洋智合”）与北京华昊中天生物医药股份有限公司（简称“北京华昊中天”）签订了《市场推广服务协议》，约定北京华昊中天指定百洋智合在区域内进行指定产品（优替德隆注射液，商品名：优替帝）的独家市场推广服务。同日，百洋智合与北京华昊中天、成都华昊中天药业有限公司签订了《市场推广服务协议补充协议》，各方同意授权百洋智合按照协议约定在区域内独占和排他地推广指定产品。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400026930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2483784239","title":"11月14日百洋医药跌5.03%，安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483784239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483784239?lang=zh_cn&edition=full","pubTime":"2024-11-14 16:20","pubTimestamp":1731572431,"startTime":"0","endTime":"0","summary":"证券之星消息，11月14日百洋医药跌5.03%，收盘报29.05元，换手率0.91%，成交量4.79万手，成交额1.43亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共23家，其中持有数量最多的公募基金为安信医药健康股票A。安信医药健康股票A目前规模为14.92亿元，最新净值1.0129，较上一交易日下跌1.75%，近一年下跌17.23%。安信医药健康股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400026065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"gpt_icon":0},{"id":"2483454841","title":"百洋医药(301015.SZ)子公司与北京华昊中天签订市场推广服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2483454841","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483454841?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:58","pubTimestamp":1731571082,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百洋医药 公告，公司全资子公司北京百洋智合医学成果转化服务有限公司与北京华昊中天生物医药股份有限公司签订了《市场推广服务协议》，约定北京华昊中天指定百洋智合在区域内进行指定产品的独家市场推广服务。同日，百洋智合与北京华昊中天、成都华昊中天药业有限公司签订了《市场推广服务协议补充协议》，各方同意授权百洋智合按照协议约定在区域内独占和排他地推广指定产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1210848.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","301015"],"gpt_icon":0},{"id":"2483464478","title":"百洋医药：签订独家市场推广服务协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2483464478","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483464478?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:46","pubTimestamp":1731570373,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0250","301015"],"gpt_icon":0},{"id":"2482721005","title":"11月12日百洋医药涨8.22%，安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482721005","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482721005?lang=zh_cn&edition=full","pubTime":"2024-11-12 16:11","pubTimestamp":1731399107,"startTime":"0","endTime":"0","summary":"证券之星消息，11月12日百洋医药涨8.22%，收盘报31.6元，换手率1.92%，成交量10.12万手，成交额3.11亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共23家，其中持有数量最多的公募基金为安信医药健康股票A。安信医药健康股票A目前规模为14.92亿元，最新净值1.0146，较上一交易日上涨1.35%，近一年下跌17.49%。安信医药健康股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200025453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2482724838","title":"百洋医药涨8.22%，中泰证券二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2482724838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482724838?lang=zh_cn&edition=full","pubTime":"2024-11-12 16:11","pubTimestamp":1731399102,"startTime":"0","endTime":"0","summary":"今日百洋医药（301015）涨8.22%，收盘报31.6元。2024年10月28日，中泰证券研究员祝嘉琦,孙宇瑶发布了对百洋医药的研报《业绩符合预期，品牌运营稳健发展》，该研报对百洋医药给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为78.7%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为天风证券的杨松。百洋医药（301015）个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200025450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","600918"],"gpt_icon":0},{"id":"2481317080","title":"百洋医药(301015.SZ)子公司拟认购Zap Medical System, Ltd.E系列优先股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481317080","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481317080?lang=zh_cn&edition=full","pubTime":"2024-11-08 21:13","pubTimestamp":1731071622,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百洋医药 公告，公司全资子公司河北百洋诚达医药有限公司、百洋健康产业国际商贸有限公司拟与标的公司Zap Medical System, Ltd.签订《首轮E系列优先股认购协议》，参与认购标的公司发行的E系列优先股。公告显示，Zap Medical System, Ltd.核心产品为头颈部X射线放射外科治疗系统，是一款专为优化颅内和颈部实体恶性肿瘤、病变治疗而设计的放射外科设备，已于2023年6月20日正式在中国获批上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1208826.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2481124910","title":"百洋医药最新公告：拟成为产品“ZAP-X®系统”及配件“兆伏闪烁探测器”独家经销商","url":"https://stock-news.laohu8.com/highlight/detail?id=2481124910","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481124910?lang=zh_cn&edition=full","pubTime":"2024-11-08 18:41","pubTimestamp":1731062468,"startTime":"0","endTime":"0","summary":"百洋医药公告，全资子公司河北百洋诚达医药有限公司、百洋健康产业国际商贸有限公司拟与Zap Medical System, Ltd.签订协议，参与认购标的公司发行的E系列优先股。同日公告，公司及全资子公司百洋健康产业国际商贸有限公司拟与ZAP Surgical Systems, Inc.签订协议，成为产品“ZAP-X®系统”及配件“兆伏闪烁探测器”在协议区域（中国包括香港和澳门）内的独家经销商。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800033499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-06-30","address":"山东省青岛市市北区桐柏路88号1号楼","stockEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0579},{"period":"3month","weight":0.285},{"period":"6month","weight":0.0309},{"period":"1year","weight":-0.2394},{"period":"ytd","weight":-0.237}],"companyName":"青岛百洋医药股份有限公司","boardCode":"AI0051","perCapita":"57519股","boardName":"批发业","registeredCapital":"52561万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":"　　青岛百洋医药股份有限公司是专业的医药产品商业化平台，主营业务是为医药产品生产企业提供商业化整体解决方案，包括提供医药产品的品牌运营、批发配送及零售，致力于成为连接医药产品和下游消费者的纽带，为品牌医药生产企业提供产品营销的综合解决方案。","serverTime":1734963866196,"listedPrice":7.64,"stockholders":"9138人(较上一季度减少1.85%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百洋医药(301015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百洋医药(301015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百洋医药,301015,百洋医药股票,百洋医药股票老虎,百洋医药股票老虎国际,百洋医药行情,百洋医药股票行情,百洋医药股价,百洋医药股市,百洋医药股票价格,百洋医药股票交易,百洋医药股票购买,百洋医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百洋医药(301015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百洋医药(301015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}